![]() N-[4-[4-[2-(difluoromethyl)-4-methoxybenzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]phenyl]-2-(dimethylamino)ethanesulfonamide结构式
![]() |
常用名 | N-[4-[4-[2-(difluoromethyl)-4-methoxybenzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]phenyl]-2-(dimethylamino)ethanesulfonamide | 英文名 | N-[4-[4-[2-(difluoromethyl)-4-methoxybenzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]phenyl]-2-(dimethylamino)ethanesulfonamide |
---|---|---|---|---|
CAS号 | 1246203-32-6 | 分子量 | 588.629 | |
密度 | 1.5±0.1 g/cm3 | 沸点 | 769.9±70.0 °C at 760 mmHg | |
分子式 | C26H30F2N8O4S | 熔点 | N/A | |
MSDS | N/A | 闪点 | 419.4±35.7 °C |
英文名 | N-[4-[4-[2-(difluoromethyl)-4-methoxybenzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]phenyl]-2-(dimethylamino)ethanesulfonamide |
---|---|
英文别名 | 更多 |
密度 | 1.5±0.1 g/cm3 |
---|---|
沸点 | 769.9±70.0 °C at 760 mmHg |
分子式 | C26H30F2N8O4S |
分子量 | 588.629 |
闪点 | 419.4±35.7 °C |
精确质量 | 588.207886 |
PSA | 135.98000 |
LogP | 2.44 |
蒸汽压 | 0.0±2.6 mmHg at 25°C |
折射率 | 1.664 |
~% N-[4-[4-[2-(dif... 1246203-32-6 |
文献:Pathway Therapeutics Limited Patent: US2010/249099 A1, 2010 ; Location in patent: Page/Page column 83 ; US 20100249099 A1 |
Ethanesulfonamide, N-[4-[4-[2-(difluoromethyl)-4-methoxy-1H-benzimidazol-1-yl]-6-(4-morpholinyl)-1,3,5-triazin-2-yl]phenyl]-2-(dimethylamino)- |
N-{4-[4-[2-(difluoromethyl)-4-methoxy-1H-benzimidazol-1-yl]-6-(4-morpholinyl)-1,3,5-triazin-2-yl]phenyl}-2-(dimethylamino)ethanesulfonamide |
N-(4-{4-[2-(Difluoromethyl)-4-methoxy-1H-benzimidazol-1-yl]-6-(4-morpholinyl)-1,3,5-triazin-2-yl}phenyl)-2-(dimethylamino)ethanesulfonamide |
N-(4-(4-(2-(difluoromethyl)-4-methoxy-1H-benzo[d]imidazol-1-yl)-6-morpholino-1,3,5-triazin-2-yl)phenyl)-2-(dimethylamino)ethanesulfonamide |